Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) — Capital Reinvestment Ratio
Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329) has a Capital Reinvestment Ratio of 0.19x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥110.78 Million) in capital expenditures (CN¥21.06 Million). See 600329 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Tianjin Zhongxin Pharmaceutical Group Corp Ltd Capital Reinvestment Ratio (2001–2024)
This chart tracks Tianjin Zhongxin Pharmaceutical Group Corp Ltd's Capital Reinvestment Ratio across 22 annual periods.
Annual Capital Reinvestment Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd (2001–2024)
Year-by-year Capital Reinvestment Ratio for Tianjin Zhongxin Pharmaceutical Group Corp Ltd from 2001 to 2024. For live market cap and broader valuation context, see Tianjin Zhongxin Pharmaceutical Group Co stock valuation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.13x | CN¥924.67 Million | CN¥117.81 Million | ▼ -37.8% |
| 2023 | 0.20x | CN¥688.49 Million | CN¥140.93 Million | ▲ +28.5% |
| 2022 | 0.16x | CN¥677.25 Million | CN¥107.90 Million | ▼ -13.5% |
| 2021 | 0.18x | CN¥852.40 Million | CN¥156.95 Million | ▼ -34.6% |
| 2020 | 0.28x | CN¥671.42 Million | CN¥189.16 Million | ▼ -32.1% |
| 2019 | 0.41x | CN¥495.49 Million | CN¥205.61 Million | ▼ -17.4% |
| 2018 | 0.50x | CN¥350.14 Million | CN¥175.81 Million | ▲ +81.4% |
| 2016 | 0.28x | CN¥419.90 Million | CN¥116.20 Million | ▲ +7.7% |
| 2015 | 0.26x | CN¥360.58 Million | CN¥92.64 Million | ▲ +5.1% |
| 2014 | 0.24x | CN¥286.85 Million | CN¥70.15 Million | ▼ -27.9% |
| 2013 | 0.34x | CN¥213.44 Million | CN¥72.42 Million | ▼ -82.9% |
| 2012 | 1.98x | CN¥20.81 Million | CN¥41.18 Million | ▲ +699.8% |
| 2011 | 0.25x | CN¥173.88 Million | CN¥43.02 Million | ▼ -50.0% |
| 2010 | 0.49x | CN¥139.04 Million | CN¥68.79 Million | ▼ -52.4% |
| 2009 | 1.04x | CN¥83.41 Million | CN¥86.74 Million | ▲ +322.2% |
| 2008 | 0.25x | CN¥155.77 Million | CN¥38.36 Million | ▼ -90.8% |
| 2007 | 2.67x | CN¥20.13 Million | CN¥53.74 Million | ▲ +366.7% |
| 2005 | 0.57x | CN¥261.91 Million | CN¥149.80 Million | ▼ -97.6% |
| 2004 | 24.04x | CN¥10.50 Million | CN¥252.31 Million | ▲ +212.4% |
| 2003 | 7.70x | CN¥76.57 Million | CN¥589.20 Million | ▲ +700.3% |
| 2002 | 0.96x | CN¥187.60 Million | CN¥180.40 Million | ▲ +13.2% |
| 2001 | 0.85x | CN¥157.73 Million | CN¥133.95 Million | — |